Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sargent

Showing results (151-160 of 514) with videos related to

Pageof 52
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2007
Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratificationH Sorbye, C-H Köhne, D J Sargent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2007
Adjuvant therapy in the elderly: making the right decisionHyman B Muss, Laura Biganzoli, Daniel J Sargent, et al.
Clinical Trials (London, England)|August 3, 2017
Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity dataJun Yin, Xavier Paoletti, Daniel J Sargent, et al.
Statistics in Medicine|November 6, 2007
A false-discovery-rate-based loss framework for selection of interactionsWei Chen, Debashis Ghosh, Trivellore E Raghunathan, et al.
Biometrics|August 16, 2011
Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific timeStuart G Baker, Daniel J Sargent, Marc Buyse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Raising the bar for antineoplastic agents: how to choose threshold values for superiority trials in advanced solid tumorsAlberto F Sobrero, Alessandro Pastorino, Daniel J Sargent, et al.
Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology|June 6, 2022
The next heartbeat: Creating dynamic and histographic Poincaré plots for the assessment of cardiac rhythmsW H Flanders, N S Moïse, R Pariaut, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Role of sensitivity analyses in assessing progression-free survival in late-stage oncology trialsSuman Bhattacharya, Gwen Fyfe, Robert J Gray, et al.
Journal of Biopharmaceutical Statistics|November 8, 2018
An adaptive multi-stage phase I dose-finding design incorporating continuous efficacy and toxicity data from multiple treatment cyclesYu Du, Jun Yin, Daniel J Sargent, et al.
Journal of Behavioral Medicine|June 1, 1986
Results of a controlled, experimental, outcome study of nondrug treatments for the control of migraine headachesJ Sargent, P Solbach, L Coyne, et al.
Pageof 52

Showing results (151-160 of 514) with videos related to

Sort By:
Pageof 52
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2007
Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratificationH Sorbye, C-H Köhne, D J Sargent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2007
Adjuvant therapy in the elderly: making the right decisionHyman B Muss, Laura Biganzoli, Daniel J Sargent, et al.
Clinical Trials (London, England)|August 3, 2017
Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity dataJun Yin, Xavier Paoletti, Daniel J Sargent, et al.
Statistics in Medicine|November 6, 2007
A false-discovery-rate-based loss framework for selection of interactionsWei Chen, Debashis Ghosh, Trivellore E Raghunathan, et al.
Biometrics|August 16, 2011
Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific timeStuart G Baker, Daniel J Sargent, Marc Buyse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Raising the bar for antineoplastic agents: how to choose threshold values for superiority trials in advanced solid tumorsAlberto F Sobrero, Alessandro Pastorino, Daniel J Sargent, et al.
Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology|June 6, 2022
The next heartbeat: Creating dynamic and histographic Poincaré plots for the assessment of cardiac rhythmsW H Flanders, N S Moïse, R Pariaut, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Role of sensitivity analyses in assessing progression-free survival in late-stage oncology trialsSuman Bhattacharya, Gwen Fyfe, Robert J Gray, et al.
Journal of Biopharmaceutical Statistics|November 8, 2018
An adaptive multi-stage phase I dose-finding design incorporating continuous efficacy and toxicity data from multiple treatment cyclesYu Du, Jun Yin, Daniel J Sargent, et al.
Journal of Behavioral Medicine|June 1, 1986
Results of a controlled, experimental, outcome study of nondrug treatments for the control of migraine headachesJ Sargent, P Solbach, L Coyne, et al.
Pageof 52